CTX-030916

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCTX-030916
Drug Alias NameCTX-030916
ClassificationSmall molecules
Mechanisms of ActionProgesterone receptor antagonists
TargetsProgesterone receptor
Therapy Area/IndicationsEndometriosisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesContext Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesContext Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEndometriosisNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A